1. Home
  2. LSTA vs MTEX Comparison

LSTA vs MTEX Comparison

Compare LSTA & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • MTEX
  • Stock Information
  • Founded
  • LSTA 1980
  • MTEX 1993
  • Country
  • LSTA United States
  • MTEX United States
  • Employees
  • LSTA N/A
  • MTEX N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • MTEX Medicinal Chemicals and Botanical Products
  • Sector
  • LSTA Health Care
  • MTEX Health Care
  • Exchange
  • LSTA Nasdaq
  • MTEX Nasdaq
  • Market Cap
  • LSTA 20.0M
  • MTEX 20.0M
  • IPO Year
  • LSTA N/A
  • MTEX 1999
  • Fundamental
  • Price
  • LSTA $2.69
  • MTEX $10.67
  • Analyst Decision
  • LSTA Strong Buy
  • MTEX
  • Analyst Count
  • LSTA 1
  • MTEX 0
  • Target Price
  • LSTA $15.00
  • MTEX N/A
  • AVG Volume (30 Days)
  • LSTA 15.4K
  • MTEX 3.3K
  • Earning Date
  • LSTA 05-08-2025
  • MTEX 05-13-2025
  • Dividend Yield
  • LSTA N/A
  • MTEX N/A
  • EPS Growth
  • LSTA N/A
  • MTEX N/A
  • EPS
  • LSTA N/A
  • MTEX N/A
  • Revenue
  • LSTA $1,000,000.00
  • MTEX $115,036,000.00
  • Revenue This Year
  • LSTA N/A
  • MTEX N/A
  • Revenue Next Year
  • LSTA N/A
  • MTEX N/A
  • P/E Ratio
  • LSTA N/A
  • MTEX N/A
  • Revenue Growth
  • LSTA N/A
  • MTEX N/A
  • 52 Week Low
  • LSTA $1.87
  • MTEX $6.75
  • 52 Week High
  • LSTA $4.20
  • MTEX $16.49
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 57.86
  • MTEX 54.88
  • Support Level
  • LSTA $2.59
  • MTEX $9.47
  • Resistance Level
  • LSTA $2.80
  • MTEX $11.07
  • Average True Range (ATR)
  • LSTA 0.19
  • MTEX 0.73
  • MACD
  • LSTA 0.00
  • MTEX 0.05
  • Stochastic Oscillator
  • LSTA 59.09
  • MTEX 62.88

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

Share on Social Networks: